[144] Tenet Healthcare Corporation New SEC Filing

Rhea-AI Filing Summary

Tenet Healthcare (THC) Form 144 summary: An insider filed a notice to sell 8,000 common shares through Fidelity Brokerage Services on or about 08/20/2025. The filing lists an aggregate market value of $1,436,278.72 and total shares outstanding of 88,351,000, meaning the proposed sale equals approximately 0.0091% of outstanding shares. All 8,000 shares were acquired by restricted stock vesting from the issuer as compensation on dates in 2023 and 2024 (658; 1,088; 3,946; 2,308). The filer reports no securities sold in the past three months and makes the required representation about lack of undisclosed material information.

Positive

• Full disclosure of broker and proposed sale details including broker name, share count, aggregate market value, and approximate sale date
• Acquisition details provided showing all 8,000 shares were acquired via restricted stock vesting as compensation with specific dates and amounts
• No securities sold in prior three months reported, simplifying aggregation calculations under Rule 144

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider plans a small sale of vested compensation shares; not material to market capitalization.

The filer intends to sell 8,000 common shares valued at $1.44 million through Fidelity on or about 08/20/2025. These shares were granted and vested as compensation across 2023 and 2024, indicating the transaction is a monetization of compensation rather than an open-market stake disposal. The sale represents roughly 0.0091% of the company's 88.35 million outstanding shares, a de minimis amount unlikely to affect liquidity or share price materially.

Compliance/Risk Analyst

TL;DR: Filing appears procedurally compliant and includes required vesting and acquisition details.

The Form 144 provides required broker, share count, aggregate value, acquisition dates, and nature of acquisition (restricted stock vesting). It also states no sales in the prior three months and includes the standard attestation regarding material nonpublic information. There is no indication in the filing of a 10b5-1 plan adoption date or other trading-plan specifics, and no adverse events or disclaimers beyond the standard notices are provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8000	1436278.72	88351000	08/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/26/2023	Restricted Stock Vesting	Issuer			658	02/26/2023	Compensation
Common	02/23/2024	Restricted Stock Vesting	Issuer			1088	02/23/2024	Compensation
Common	02/24/2024	Restricted Stock Vesting	Issuer			3946	02/24/2024	Compensation
Common	03/01/2024	Restricted Stock Vesting	Issuer			2308	03/01/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Tenet Healthcare's (THC) Form 144 say about the proposed sale?

The notice states an insider intends to sell 8,000 common shares through Fidelity on or about 08/20/2025 with an aggregate market value of $1,436,278.72.

How were the 8,000 shares acquired according to the filing?

All shares were acquired via restricted stock vesting as compensation on 02/26/2023 (658), 02/23/2024 (1,088), 02/24/2024 (3,946), and 03/01/2024 (2,308).

What percentage of Tenet Healthcare's outstanding shares does the proposed sale represent?

The filing shows 8,000 shares versus 88,351,000 outstanding, approximately 0.0091% of the company's outstanding shares.

Which broker will handle the sale listed on the Form 144?

The broker named in the filing is Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield RI 02917.

Did the filer report any securities sold in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

Does the Form 144 include any representation about material nonpublic information?

Yes, the filer signs the standard representation that they do not know any material adverse information about the issuer that has not been publicly disclosed.